AAPL 204.715 -8.5645% MSFT 376.635 -1.4406% NVDA 102.99 -6.7289% GOOGL 151.93 -3.2539% GOOG 153.84 -3.16% AMZN 181.72 -7.2904% META 548.01 -6.1514% AVGO 157.085 -8.7193% LLY 803.48 -1.8015% TSLA 269.8415 -4.5687% TSM 159.3 -6.5086% V 342.755 -1.0323% JPM 231.3248 -5.8967% UNH 544.91 4.1495% NVO 67.635 -0.8866% WMT 88.83 -1.0361% LVMUY 120.285 -3.5405% XOM 113.61 -4.2639% LVMHF 605.0 -2.8144% MA 538.0 -1.7136%
AAPL 204.715 -8.5645% MSFT 376.635 -1.4406% NVDA 102.99 -6.7289% GOOGL 151.93 -3.2539% GOOG 153.84 -3.16% AMZN 181.72 -7.2904% META 548.01 -6.1514% AVGO 157.085 -8.7193% LLY 803.48 -1.8015% TSLA 269.8415 -4.5687% TSM 159.3 -6.5086% V 342.755 -1.0323% JPM 231.3248 -5.8967% UNH 544.91 4.1495% NVO 67.635 -0.8866% WMT 88.83 -1.0361% LVMUY 120.285 -3.5405% XOM 113.61 -4.2639% LVMHF 605.0 -2.8144% MA 538.0 -1.7136%

Search News

Latest News

UBS raises rating on Fluor Corp.; expects shares to rise by over 35%
UBS raises rating on Fluor Corp.; expects shares to rise by over 35%
BMO positive on Structure Therapeutics; expects stock price to shoot up by 40%
BMO positive on Structure Therapeutics; expects stock price to shoot up by 40%

Premium

Target share price gets a boost from BofA rating upgrade
Target share price gets a boost from BofA rating upgrade

Premium

Brokers initiate coverage on Neumora Therapeutics with a Buy rating
Brokers initiate coverage on Neumora Therapeutics with a Buy rating

Premium

BofA ups target price on on Eli Lilly, stock jumps
BofA ups target price on on Eli Lilly, stock jumps